Hjem
Trond Bruuns bilde

Trond Bruun

Førsteamanuensis, UiB. Seksjonsoverlege, Haukeland universitetssykehus
  • E-postTrond.Bruun@uib.no
  • Besøksadresse
    Med. avd., Haukeland universitetssykehus
    5021 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen

Trond Bruun er seksjonsoverlege ved Infeksjonsseksjonen , Medisinsk klinikk, Haukeland universitetssykehus og 1. amanuensis II ved Klinisk institutt 2, UiB. Viktigste forskningfelt er innen alvorlige hud- og bløtvevsinfeksjoner, spesielt erysipelas, cellulitt og nekrotiserende fasciitt forårsaket av Streptococcus pyogenes og Streptococcus dysgalactiae. Forskningen fokuserer først og fremst på klinisk epidemiologi, kliniske trekk og behandling sett i relasjon til verten og bakterienes egenskaper. For tiden deltar Bruun og streptokokkforskningsgruppen ved Universitetet i Bergen og Haukeland universitetssykehus i PERMIT- og PERAID-prosjektene (https://permedinfect.com/) finansiert av Nordforsk og EU. Disse prosjektene har som mål å fremme forskning på persontilpasset medisin (PM) ved alvorlige infeksjonssykdommer, spesielt  livstruende nekrotiserende bløtvevsinfeksjoner (NSTI) og sepsis.

Vitenskapelig artikkel
  • Vis forfatter(e) (2024). How good are surgeons at disclosing periprosthetic joint infection at the time of revision, based on pre- and intra-operative assessment? A study on 16,922 primary total hip arthroplasties reported to the Norwegian Arthroplasty Register. Acta Orthopaedica. 67-72.
  • Vis forfatter(e) (2023). Systemic immune activation profiles in streptococcal necrotizing soft tissue infections: A prospective multicenter study. Clinical Immunology.
  • Vis forfatter(e) (2022). Clinical Characteristics and Histopathology in Suspected Necrotizing Soft Tissue Infections. Open Forum Infectious Diseases. 7 sider.
  • Vis forfatter(e) (2022). Analysis of host-pathogen gene association networks reveals patient-specific response to streptococcal and polymicrobial necrotising soft tissue infections. BMC Medicine.
  • Vis forfatter(e) (2021). Discriminatory plasma biomarkers for specific endotypes of necrotizing soft tissue infections. Journal of Clinical Investigation.
  • Vis forfatter(e) (2020). Risk factors and Predictors of Mortality in Streptococcal Necrotizing Soft-Tissue Infections: A Multicenter Prospective Study. Clinical Infectious Diseases. 293-300.
  • Vis forfatter(e) (2020). Non-purulent skin and soft tissue infections: predictive power of a severity score and the appropriateness of treatment in a prospective cohort. Infectious Diseases. 361-371.
  • Vis forfatter(e) (2019). Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Medicine. 1241-1251.
  • Vis forfatter(e) (2019). Molecular profiling of tissue biopsies reveals unique signatures associated with streptococcal necrotizing soft tissue infections. Nature Communications. 1-15.
  • Vis forfatter(e) (2018). Pivotal role of prexexisting pathogen-spesific antibodies in the development of necrotizing soft-tissue infections. . Journal of Infectious Diseases.
  • Vis forfatter(e) (2018). Pivotal Role of Preexisting Pathogen-Specific Antibodies in the Development of Necrotizing Soft-Tissue Infections. Journal of Infectious Diseases. 44-52.
  • Vis forfatter(e) (2018). Necrotizing soft tissue infections ? a multicentre, prospective observational study (INFECT): protocol and statistical analysis plan. Acta Anaesthesiologica Scandinavica. 272-279.
  • Vis forfatter(e) (2018). Aetiology and clinical features of facial cellulitis: a prospective study. Infectious Diseases. 27-34.
  • Vis forfatter(e) (2017). Association between cytokine response, the LRINEC score and outcome in patients with necrotising soft tissue infection: A multicentre, prospective study. Scientific Reports. 1-12.
  • Vis forfatter(e) (2016). Etiology of cellulitis and clinical prediction of streptococcal disease: A prospective study. Open Forum Infectious Diseases.
  • Vis forfatter(e) (2016). Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors. Clinical Infectious Diseases. 1034-1041.
  • Vis forfatter(e) (2015). Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections. Scientific Reports.
  • Vis forfatter(e) (2013). Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp equisimilis of groups C and G in western Norway. Clinical Microbiology and Infection (CMI). E545-E550.
  • Vis forfatter(e) (2011). Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clinical Microbiology and Infection (CMI). 358-364.
  • Vis forfatter(e) (2010). Clinical, microbiological and molecular characteristics of six cases of group A streptococcal meningitis in western Norway. Scandinavian Journal of Infectious Diseases. 665-671.
Leserinnlegg
  • Vis forfatter(e) (2021). Kontaktreduserende tiltak er en trygg og nødvendig bro til vårens vaksinasjon. . Bergens Tidende.
Brev til redaktøren
  • Vis forfatter(e) (2016). Etiology of cellulitis and the validity of new and old methods. Clinical Infectious Diseases. 954-955.
Doktorgradsavhandling
  • Vis forfatter(e) (2016). Clinical and bacterial diversity in streptococcal skin and soft tissue disease.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2021). Antibiotic-loaded bone cement in prevention of periprosthetic joint infections in primary total knee arthroplasty: A register-based multicentre randomised controlled non-inferiority trial (ALBA trial). BMJ Open. 1-8.

Se fullstendig oversikt over publikasjoner i CRIStin.